Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.

Journal of proteome research - 2 Jan 2015

Luan Hemi, Liu Liang-Feng, Meng Nan, Tang Zhi, Chua Ka-Kit, Chen Lei-Lei, Song Ju-Xian, Mok Vincent C T, Xie Li-Xia, Li Min, Cai Zongwei

Abstract excerpt

Increasing evidence has shown that abnormal metabolic phenotypes in body fluids reflect the pathogenesis and pathophysiology of Parkinson's disease (PD). These body fluids include urine; however, the relationship between, specifically, urinary metabolic phenotypes and PD is not fully understood. In this study, urinary metabolites from a total of 401 clinical urine samples collected from 106 idiopathic PD patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to alpha-Synuclein
Share to Chromatography, Liquid

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Histidine

Share to Kynurenine

Share to Metabolomics

Share to Phenylalanine

Share to Steroids

Share to Tryptophan

Source

Identifiers

PMID: 25271123
DOI: 10.1021/pr500807t

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

LC-MS-based urinary metabolite signatures in idiopathic Parkinson's disease.PMID 25271123Read ↗

Comprehensive urinary metabolomic profiling and identification of potential noninvasive marker for idiopathic Parkinson's disease.Semantic proximity Read ↗

Biomarker Research in Parkinson’s Disease Using Metabolite ProfilingSemantic proximity Read ↗

Comparative Proteomic Analysis of Environmental and Genetic Models of Parkinson’s Disease Highlights the Role of Purine MetabolismSemantic proximity Read ↗

Untargeted Plasma Metabolomics Unveils Distinct Metabolite Profiles in Parkinson’s Disease Subtypes: A Focus on idiopathic REM Sleep Behavior DisordersSemantic proximity Read ↗

Metabolic Profiling of CSF from People Suffering from Sporadic and LRRK2 Parkinson's Disease: A Pilot Study.Semantic proximity Read ↗

Urinary proteome profiling for stratifying patients with familial Parkinson's disease.Semantic proximity Read ↗

Urinary proteome profiling for stratifying patients with familial Parkinson’s diseaseSemantic proximity Read ↗

Discovery of Sexual Dimorphism in the Serum Metabolome of Parkinson’s Disease Patients Harboring Rare Genetic Variants with Uncertain PathogenicitySemantic proximity Read ↗

Levodopa and dopamine dynamics in Parkinson’s disease metabolomicsSemantic proximity Read ↗

The role of dopaminergic medication, lipid, and endocannabinoid pathway alterations in idiopathic and<i>PRKN/PINK1</i>-mediated Parkinson’s disease – a large-scale targeted metabolomics studySemantic proximity Read ↗

Sex differences impact serum metabolome profiles in patients with familial Parkinson’s diseaseSemantic proximity Read ↗

Metabolomic profiling in LRRK2-related Parkinson's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.